Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
@article{Connery2015MedicationAssistedTO, title={Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions}, author={Hilary S Connery}, journal={Harvard Review of Psychiatry}, year={2015}, volume={23}, pages={63–75} }
Learning ObjectiveAfter participating in this activity, learners should be better able to: Evaluate the rationale for and current evidence supporting medication-assisted treatment of opioid use disorder. AbstractMedication-assisted treatment of opioid use disorder with physiological dependence at least doubles rates of opioid-abstinence outcomes in randomized, controlled trials comparing psychosocial treatment of opioid use disorder with medication versus with placebo or no medication. This…
331 Citations
Buprenorphine Treatment for Opioid Use Disorder: An Overview
- Biology, MedicineCNS Drugs
- 2019
The different formulations of buprenorphine are reviewed, including newer long-acting injectable formulations that may decrease the risk of diversion and improve adherence and the barriers, challenges, risks, and efficacy of buPrenorphines treatment vs. other treatments.
Buprenorphine implants in medical treatment of opioid addiction
- Medicine, BiologyExpert review of clinical pharmacology
- 2017
Long-acting implantable drug formulations that offer consistent drug delivery and lower risk of misuse, diversion, or accidental pediatric exposure over traditional formulations represent a promising development for the effective treatment of opioid use disorder.
Review of medication-assisted treatment for opioid use disorder
- MedicineJournal of osteopathic medicine
- 2022
This review will define the components of MAT, consider the impact of MAT in the primary care setting, and identify barriers to effective MAT.
Opioid Use Disorder: Medical Treatment Options.
- MedicineAmerican family physician
- 2019
Family physicians are ideally positioned to diagnose opioid use disorder, provide evidence-based treatment with buprenorphine or naltrexone, refer patients for methadone as appropriate, and lead the response to the current opioid crisis.
Treatment Approaches for Opioid Use Disorders in Late Life
- MedicineCurrent Treatment Options in Psychiatry
- 2018
In order to optimally address OUD in older adults, a multi-dimensional approach involving pharmacotherapy in combination with psychosocial treatments is recommended.
Management of Opioid Misuse and Opioid Use Disorders Among Youth
- Medicine, PsychologyPediatrics
- 2020
Growing evidence supports the need for integration of OUD treatment into primary care, and research and expert consensus suggest the use of brief interventions focused on reducing risks associated with ongoing opioid use and using motivational interviewing strategies to engage youth in treatment.
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
- MedicineCannabis and cannabinoid research
- 2018
Emerging evidence that suggests that cannabis may play a role in ameliorating the impact of OUD is reviewed and the compelling nature of these data and the relative safety profile of cannabis warrant further exploration of cannabis as an adjunct or alternative treatment for OUD.
Development of an integrated cognitive behavioral therapy for anxiety and opioid use disorder: Study protocol and methods.
- PsychologyContemporary clinical trials
- 2017
Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review
- MedicineJournal of General Internal Medicine
- 2020
Evidence supports the practice of continuing methadone or buprenorphine for most patients during acute pain episodes, but well-described, prospective studies of adjuvant pain management strategies when OUD medications are continued would add to the existing literature base.
Opioid Misuse as a Predictor of Alcohol Treatment Outcomes in the COMBINE Study: Mediation by Medication Adherence
- Medicine, PsychologyAlcoholism, clinical and experimental research
- 2018
Medication adherence partially mediated the association between opioid misuse, cannabis use, other drug use, and treatment outcomes, which was partially mediated by medication adherence.
References
SHOWING 1-10 OF 135 REFERENCES
A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction.
- Psychology, MedicineClinical psychology review
- 2010
Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
- Psychology, MedicineArchives of general psychiatry
- 2005
Combining buprenorphine with behavioral interventions is significantly more efficacious in the treatment of opioid-dependent adolescents relative to combining clonidine and behavioral interventions.
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
- Medicine, PsychologyJournal of addictive diseases
- 2012
Results indicate that maintenance medication provides the best opportunity for patients to achieve recovery from opiate addiction, and selection of medication should be based on informed choice following a discussion of outcomes, risks, and benefits of each medication.
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
- Medicine, PsychologyJAMA
- 2010
Among persons with opioid dependence, the use of buprenorphine implants compared with placebo resulted in less opioid use over 16 weeks as assessed by urine samples and a greater change on clinician global ratings of severity of opioid dependence.
Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
- MedicineArchives of general psychiatry
- 2011
Prescription opioid-dependent patients are most likely to reduce opioid use during buprenorphine-naloxone treatment; if tapered off bupreliminary treatment, even after 12 weeks of treatment, the likelihood of an unsuccessful outcome is high, even in patients receiving counseling in addition to SMM.
Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice
- Medicine, BiologyThe American journal of drug and alcohol abuse
- 2012
Among the current detoxification regimens, the available clinical and scientific data suggest that the best approach may be using an initial 2–4 mg dose of buprenorphine combined with clonidine, other ancillary medications, and progressively increasing doses of oral naltrexone over 3–5 days up to the target dose of nalt Rexone.
Psychosocial treatment for opiate abuse and dependence.
- Psychology, MedicineThe Cochrane database of systematic reviews
- 2005
Both Enhanced Outreach Counselling and Brief Reinforcement Based Intensive Outpatient Therapy coupled with Contingency Management had significantly better outcomes than standard therapy within treatment, regarding relapse to opioid use, re-enrollment in treatment and retention in treatment.
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
- MedicineThe Cochrane database of systematic reviews
- 2002
Methadone is an effective maintenance therapy intervention for the treatment of heroin dependence as it retains patients in treatment and decreases heroin use better than treatments that do not utilise opioid replacement therapy, and does not show a statistically significant superior effect on criminal activity.
Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
- Medicine, PsychologyPain physician
- 2012
The current state of knowledge regarding the growing problem of opioid abuse and misuse; known risk factors; and methods of predicting, assessing, monitoring, and addressing opioid Abuse and misuse in patients with chronic noncancer pain are reviewed.
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
- Medicine, PsychologyAddiction
- 2014
AIMS
To examine patient and medication characteristics associated with retention and continued illicit opioid use in methadone (MET) versus buprenorphine/naloxone (BUP) treatment for opioid…